These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2990147)
1. Characterization of four human malignant glioma cell lines. Studer A; de Tribolet N; Diserens AC; Gaide AC; Matthieu JM; Carrel S; Stavrou D Acta Neuropathol; 1985; 66(3):208-17. PubMed ID: 2990147 [TBL] [Abstract][Full Text] [Related]
2. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398 [TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines. Abaza MS; Narayan RK; Atassi MZ Jpn J Cancer Res; 1997 Nov; 88(11):1094-9. PubMed ID: 9439685 [TBL] [Abstract][Full Text] [Related]
4. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959 [TBL] [Abstract][Full Text] [Related]
5. Immunological, biochemical, ultrastructural, and electrophysiological characteristics of a human glioblastoma-derived cell culture line. Black PM; Kornblith PL; Davison PF; Liszczak TM; Merk LP; Smith BH; McKeever PE; Quindlen EA J Neurosurg; 1982 Jan; 56(1):62-72. PubMed ID: 6275048 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of five cell lines derived from human malignant gliomas. Rutka JT; Giblin JR; Dougherty DY; Liu HC; McCulloch JR; Bell CW; Stern RS; Wilson CB; Rosenblum ML Acta Neuropathol; 1987; 75(1):92-103. PubMed ID: 2829496 [TBL] [Abstract][Full Text] [Related]
7. Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors. Bilzer T; Stavrou D; Wechsler W; Wöhler B; Keiditsch E Anticancer Res; 1991; 11(2):547-53. PubMed ID: 2064311 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous demonstration of glia- and glioma-associated antigens in human astrocytomas. Bilzer T; Martin B; Stavrou D; Keiditsch E Int J Cancer Suppl; 1988; 2():41-4. PubMed ID: 3162445 [TBL] [Abstract][Full Text] [Related]
9. Characterization of an established human malignant glioma cell line: LN-18. Diserens AC; de Tribolet N; Martin-Achard A; Gaide AC; Schnegg JF; Carrel S Acta Neuropathol; 1981; 53(1):21-8. PubMed ID: 7211194 [TBL] [Abstract][Full Text] [Related]
10. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Bocchini V; Casalone R; Collini P; Rebel G; Lo Curto F Cell Tissue Res; 1991 Jul; 265(1):73-81. PubMed ID: 1655272 [TBL] [Abstract][Full Text] [Related]
11. Characterization of adherent primary cell lines from fresh human glioblastoma tissue, defining glial fibrillary acidic protein as a reliable marker in establishment of glioblastoma cell culture. Grube S; Freitag D; Kalff R; Ewald C; Walter J Cancer Rep (Hoboken); 2021 Apr; 4(2):e1324. PubMed ID: 33251771 [TBL] [Abstract][Full Text] [Related]
12. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438 [TBL] [Abstract][Full Text] [Related]